U.S. flag

An official website of the United States government

NM_001079802.2(FKTN):c.1325A>G (p.Asn442Ser) AND Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Oct 1, 2021
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001729816.1

Allele description [Variation Report for NM_001079802.2(FKTN):c.1325A>G (p.Asn442Ser)]

NM_001079802.2(FKTN):c.1325A>G (p.Asn442Ser)

Gene:
FKTN:fukutin [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
9q31.2
Genomic location:
Preferred name:
NM_001079802.2(FKTN):c.1325A>G (p.Asn442Ser)
HGVS:
  • NC_000009.12:g.105635203A>G
  • NG_008754.1:g.82074A>G
  • NM_001079802.2:c.1325A>GMANE SELECT
  • NM_001198963.2:c.1270+55A>G
  • NM_001351496.2:c.1325A>G
  • NM_001351497.2:c.1256A>G
  • NM_001351498.2:c.*117A>G
  • NM_001351499.2:c.929A>G
  • NM_001351500.2:c.929A>G
  • NM_001351501.2:c.929A>G
  • NM_001351502.2:c.929A>G
  • NM_006731.2:c.1325A>G
  • NP_001073270.1:p.Asn442Ser
  • NP_001338425.1:p.Asn442Ser
  • NP_001338426.1:p.Asn419Ser
  • NP_001338428.1:p.Asn310Ser
  • NP_001338429.1:p.Asn310Ser
  • NP_001338430.1:p.Asn310Ser
  • NP_001338431.1:p.Asn310Ser
  • NP_006722.2:p.Asn442Ser
  • LRG_434t1:c.1325A>G
  • LRG_434t2:c.1325A>G
  • LRG_434:g.82074A>G
  • LRG_434p2:p.Asn442Ser
  • NC_000009.11:g.108397484A>G
  • NM_001079802.1:c.1325A>G
  • NM_006731.2:c.1325A>G
  • NR_147213.2:n.1448A>G
  • NR_147214.2:n.1620A>G
Protein change:
N310S
Links:
dbSNP: rs1429464723
NCBI 1000 Genomes Browser:
rs1429464723
Molecular consequence:
  • NM_001351498.2:c.*117A>G - 3 prime UTR variant - [Sequence Ontology: SO:0001624]
  • NM_001198963.2:c.1270+55A>G - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001079802.2:c.1325A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001351496.2:c.1325A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001351497.2:c.1256A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001351499.2:c.929A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001351500.2:c.929A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001351501.2:c.929A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001351502.2:c.929A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_006731.2:c.1325A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NR_147213.2:n.1448A>G - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_147214.2:n.1620A>G - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4 (MDDGA4)
Synonyms:
Fukuyama type muscular dystrophy; Muscular dystrophy, congenital progressive, with mental retardation; Muscular dystrophy, congenital, with central nervous system involvement; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0009678; MedGen: C0410174; Orphanet: 588; Orphanet: 899; OMIM: 253800

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001976961Laboratory of Medical Genetics, National & Kapodistrian University of Athens
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Oct 1, 2021)
maternalclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedmaternalyesnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Phenotype-driven variant filtration strategy in exome sequencing toward a high diagnostic yield and identification of 85 novel variants in 400 patients with rare Mendelian disorders.

Marinakis NM, Svingou M, Veltra D, Kekou K, Sofocleous C, Tilemis FN, Kosma K, Tsoutsou E, Fryssira H, Traeger-Synodinos J.

Am J Med Genet A. 2021 Aug;185(8):2561-2571. doi: 10.1002/ajmg.a.62338. Epub 2021 May 19.

PubMed [citation]
PMID:
34008892

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee.

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Laboratory of Medical Genetics, National & Kapodistrian University of Athens, SCV001976961.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

PM2, PM3, PP3, PP5

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1maternalyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 8, 2024